Table 3. Exploratory Analysis of Live-Born Infants at 22, 23, or 24 Weeks’ Gestational Age During 2004-2007 or 2014-2016 in Swedena.
22 Weeks’ Gestational Ageb | 23 Weeks’ Gestational Age | 24 Weeks’ Gestational Age | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
No. With Event/Total (%) | Difference, % (95% CI)d |
P Value | No. With Event/Total (%) | Difference, % (95% CI)d |
P Value | No. With Event/Total (%) | Difference, % (95% CI)d |
P Value | ||||
2004-2007c | 2014-2016 | 2004-2007c | 2014-2016 | 2004-2007c | 2014-2016 | |||||||
Infant Characteristics | ||||||||||||
Male sex | 25/49 (51) |
39/74 (53) |
−2 (−20 to 16) |
>.99 | 55/101 (55) |
82/148 (55) |
−1 (−14 to 12) |
.90 | 78/144 (54) |
119/192 (62) |
−8 (−18 to 2.8) |
.18 |
Female sex | 24/49 (49) |
35/74 (47) |
2 (−16 to 20) |
>.99 | 46/101 (45) |
66/148 (45) |
1 (−12 to 14) |
.90 | 66/144 (46) |
73/192 (38) |
8 (−2.8 to 18) |
.18 |
Singleton | 29/49 (59) |
54/74 (73) |
−14 (−31 to 3.3) |
.16 | 85/101 (84) |
115/148 (78) |
6 (−3.3 to 16) |
.26 | 112/144 (78) |
165/192 (86) |
−8 (−17 to 0.7) |
.06 |
Twin or triplet | 20/49 (41) |
20/74 (27) |
14 (−3.3 to 31) |
.16 | 16/101 (16) |
33/148 (22) |
−6 (−16 to 3.3) |
.26 | 32/144 (22) |
27/192 (14) |
8 (−0.7 to 17) |
.06 |
Apgar score <4e | ||||||||||||
At 1 min after birth | 34/49 (69) |
49/73 (67) |
2 (−15 to 19) |
.94 | 53/101 (53) |
77/145 (53) |
−0.6 (−13 to 12) |
>.99 | 63/144 (44) |
76/188 (40) |
3 (−7.4 to 14) |
.58 |
At 5 min after birth | 38/49 (71) |
35/71 (49) |
28 (12 to 44) |
.003 | 47/101 (47) |
42/146 (29) |
18 (5.6 to 30) |
.005 | 47/144 (33) |
44/188 (23) |
9 (−0.5 to 19) |
.06 |
Small for gestational agef | 3/49 (6) |
4/73 (5.5) |
0.6 (−7.9 to 9.1) |
>.99 | 7/100 (7.0) |
14/146 (9.6) |
−3 (−0.5 to 4.3) |
.64 | 16/142 (11) |
31/187 (17) |
−5 (−13 to 2.1) |
.20 |
Birth weight, median (range), g | 519 (290 to 730) |
489 (345 to 670) |
24 (−195 to 310) |
.12 | 590 (320 to 808) |
592 (300 to 1615) |
−1 (−295 to 270) |
.82 | 674 (374 to 1070) |
680 (380 to 930) |
−5 (−300 to 363) |
.46 |
Obstetric Care Management | ||||||||||||
Any antenatal steroids | 19/47 (40) |
47/73 (64) |
−24 (−42 to −6.1) |
.02 | 85/99 (86) |
132/144 (92) |
−6 (−14 to 2.4) |
.20 | 130/137 (95) |
169/187 (90) |
5 (−1.1 to 10) |
.15 |
Cesarean delivery | 2/49 (4.1) |
4/74 (5.4) |
1 (−8.9 to 6.2) |
>.99 | 17/101 (17) |
50/148 (34) |
−17 (−28 to −6.4) |
.003 | 67/144 (46) |
110/191 (58) |
−11 (−22 to −0.3) |
.05 |
Delivery at hospital with level III NICU | 22/49 (45) |
66/74 (89) |
−44 (−60 to −29) |
<.001 | 79/101 (78) |
127/148 (86) |
−8 (−17 to 2.2) |
.13 | 129/144 (90) |
162/192 (84) |
5 (−2.0 to 12) |
.20 |
Delivery at hospital with level I-II NICU | 27/49 (55) |
8/74 (11) |
44 (29 to 60) |
<.001 | 22/101 (22) |
21/148 (14) |
8 (−2.7 to 18) |
.13 | 15/144 (10) |
30/192 (16) |
−5 (−12 to 2.0) |
.20 |
Neonatal Care Management | ||||||||||||
Neonatologist attending the birth | 22/48 (46) |
66/73 (90) |
−45 (−60 to −29) |
<.001 | 83/100 (83) |
132/147 (90) |
−7 (−16 to 2.0) |
.13 | 130/142 (92) |
168/192 (88) |
4 (−2.5 to 11) |
.29 |
Intubation at birth | 12/21 (57) |
52/74 (70) |
−13 (−37 to 10) |
.38 | 68/84 (81) |
129/148 (87) |
−6 (−16 to 3.8) |
.25 | 113/142 (80) |
160/192 (83) |
−4 (−12 to 4.7) |
.39 |
Surfactant administration <2 h after birth | 13/42 (31) |
50/74 (68) |
−37 (−54 to −19) |
<.001 | 72/95 (76) |
116/140 (83) |
−7 (−18 to 3.6) |
.19 | 120/140 (86) |
150/185 (81) |
5 (−3.5 to 13) |
.30 |
Admission to NICUg | 18/48 (38) |
50/74 (68) |
−30 (−47 to −13) |
<.001 | 81/100 (81) |
138/148 (93) |
−12 (−21 to −3.6) |
.004 | 132/142 (93) |
191/192 (99) |
−7 (−11 to −2.2) |
.001 |
Transportation of infant to level III NICU | 6/49 (12) |
6/74 (8.1) |
4 (−7.0 to 15) |
.65 | 13/101 (13) |
16/148 (11) |
2 (−6.2 to 10) |
.62 | 15/144 (10) |
24/192 (13) |
−2 (−8.9 to 4.8) |
.56 |
Abbreviation: NICU, neonatal intensive care unit.
Data for live-born infants at 25 or 26 weeks’ gestational age appear in Table 4.
Data for 22 infants identified in the Swedish medical birth registry but who were dead before admission were excluded from the data presented in the majority of rows.
Data are from Fellman et al.16
Difference in the prevalence for the 2004-2007 cohort minus the prevalence for the 2014-2016 cohort.
A score of 10 represents the best possible condition.
Some birth weights were missing because infants were not weighed until after birth.
Data for the 22 infants were included in this row (identified in the Swedish medical birth registry but who were dead before admission).